Short answer · Medically reviewed summary · Last updated: 2026-04-07
Aplastic anemia is a condition where the bone marrow fails to produce enough new blood cells, primarily caused by an autoimmune process where the body’s immune system mistakenly attacks its own hematopoietic stem cells. While the exact trigger remains unknown in approximately 70% of cases, the condition is categorized as idiopathic, though genetic predispositions and environmental exposures can also play significant roles in its development. What causes the bone marrow to fail in Aplastic Anemia? The core mechanism of Aplastic Anemia involves the destruction of hematopoietic stem cells—the "mother cells" in your bone marrow that create red blood cells, white blood cells, and platelets.
2 people with Aplastic Anemia have shared their first-person experience on this question at DiseaseMaps.
Aplastic anemia is a condition where the bone marrow fails to produce enough new blood cells, primarily caused by an autoimmune process where the body’s immune system mistakenly attacks its own hematopoietic stem cells. While the exact trigger remains unknown in approximately 70% of cases, the condition is categorized as idiopathic, though genetic predispositions and environmental exposures can also play significant roles in its development.
The core mechanism of Aplastic Anemia involves the destruction of hematopoietic stem cells—the "mother cells" in your bone marrow that create red blood cells, white blood cells, and platelets. Think of the bone marrow as a factory; in Aplastic Anemia, the factory floor is essentially cleared out. In the majority of patients, this occurs because the immune system’s T-cells become overactive and target these stem cells for destruction. This leads to a circulatory system struggling with low oxygen (anemia), a weakened immune system prone to infection, and a reduced ability for the blood to clot.
While most cases of Aplastic Anemia are acquired rather than inherited, clinical genetics plays a vital role in diagnosis. Inherited bone marrow failure syndromes, such as Fanconi anemia or dyskeratosis congenita, can present with symptoms that mimic Aplastic Anemia. Geneticists often screen for mutations in specific genes (like TERT or TERC, which relate to telomere maintenance) to distinguish between acquired Aplastic Anemia and these hereditary conditions. Understanding these genetic markers is essential, as they can influence the success of treatments like bone marrow transplants.
Distinguishing between a "cause" and a "risk factor" is important: a cause directly triggers the immune attack, whereas a risk factor increases the likelihood of the disease developing. Research indicates that the following factors may contribute to the onset of Aplastic Anemia:
Despite significant advancements in hematology, the etiology of Aplastic Anemia remains an active area of research. We understand the "how"—the T-cell-mediated destruction—but we do not yet fully understand the "why." Researchers are currently investigating why the immune system suddenly decides to target healthy marrow. At DiseaseMaps.org, 357 community members are sharing their journeys, which helps researchers better understand the heterogeneous nature of this condition. Ongoing studies are utilizing advanced genomic sequencing to identify new biomarkers that might predict how a patient will respond to treatments like rATG (rabbit anti-thymocyte globulin) or hATG (horse anti-thymocyte globulin).
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.